ロード中...
The Use of the Selective Imidazoline I(1) Receptor Agonist Carbophenyline as a Strategy for Neuropathic Pain Relief: Preclinical Evaluation in a Mouse Model of Oxaliplatin-Induced Neurotoxicity
Anti-cancer therapy based on the repeated administration of oxaliplatin is limited by the development of a disabling neuropathic syndrome with detrimental effects on the patient’s quality of life. The lack of effective pharmacological approaches calls for the identification of innovative therapeutic...
保存先:
| 出版年: | Neurotherapeutics |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7609613/ https://ncbi.nlm.nih.gov/pubmed/32572830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-020-00873-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|